Home Study Details

    Program Type

    Home Study


    2 Contact Hour(s)

    Release Date

    Monday, November 2, 2020

    Offline Date

    Thursday, November 2, 2023

    ACPE Expiration Date

    Thursday, November 2, 2023

    Target Audience




    • Overview

      We live in an “Opioid Crisis” where someone dies approximately every 7 minutes from drug overdose. So just how do we end this “Opioid Crisis”, or at least, how do we as healthcare professionals contribute to the progress of moving society in the right direction? In this monograph, we will review overall pain management etiology; risk reduction strategies (psychological and opioid risk screenings, urine drug monitoring, etc.), numerous non-pharmacological and pharmacological treatment options (with particular attention on opioid medications), opioid overdose reversal treatments; along with not only how to identify drug seeking and diversion behaviors, but possible actions to take when the behaviors are suspected. The Florida PDMP known as E-FORCSE will of course also be discussed for its expected impact on adherence and diversion. We will also review Federal and Florida specific controlled substance laws and trends such as controlled substance classifications, prescribing authorities, the 2018 Florida Statue Update, the naloxone standing order, and DEA Red Flags. Unlike opioids, this monograph is intended to open one’s eyes, elevate blood pressure and/or heart rate, and increase cognition!

      This course has been FL Board Approved to fulfil the 2.0 hour requirement of training for validation of prescriptions for controlled substances for pharmacists only.


      • Homestudy PDF :   20216H08(001).pdf

      Financial Support By

    • Pharmacist

      Recognize proper storage and disposal protocols for controlled substances.
      Recognize the relevance of the Florida standing order for naloxone for the emergency treatment of opioid overdose.
      Recall protocols for addressing and resolving problems recognized during the drug utilization review including drug/drug interactions, side effects, high dose and low dose guidelines, and other therapeutic concerns.
      Recall the laws and rules related to the prescribing and dispensing of controlled substances in Florida.
      Identify the most clinically important patient counseling considerations for patients utilizing opioid medications.
      Recall available treatment resources for opioid physical dependence, addiction, misuse, or abuse.
      Recall the legal expectations and intentions of utilizing the Florida Prescription Drug Monitoring Program’s Database (E-FORCSE).
      Recognize how to ensure access to controlled substances for all patients with a valid prescription, while also assessing prescriptions for appropriate therapeutic value and detecting prescriptions not based on legitimate medical purpose.
      Recall pain management non-pharmacological and pharmacological (both opioid and non-opioid) treatment options and respective dosage and patient counseling considerations.
    • Activity Type


      CE Broker


      Universal Activity Number

      Pharmacist 0798-0000-20-216-H08-P

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones

    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Firefox 3.0.3 or higher
    Adobe Acrobat Reader

    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).